Article Information
PubMed
Published By
Print ISSN
Online ISSN
History
- Received December 4, 2019
- Accepted August 24, 2020
- Published online October 7, 2020.
Article Versions
- Earlier version (September 29, 2020 - 11:35).
- You are viewing the most recent version of this article.
Copyright & Usage
Copyright © 2020 by the American Society of Nephrology
Author Information
- Adeera Levin1,
- Vlado Perkovic2,
- David C. Wheeler2,3,
- Stefan Hantel4,
- Jyothis T. George5,
- Maximilian von Eynatten5,
- Audrey Koitka-Weber5,6,7,
- Christoph Wanner7,
- on behalf of the EMPA-REG OUTCOME Investigators*
- 1Division of Nephrology, University of British Columbia, Vancouver, Canada
- 2The George Institute for Global Health, University of New South Wales, Sydney, Australia
- 3Centre for Nephrology, University College London, London, United Kingdom
- 4Boehringer Ingelheim Pharma GmbH & Co. KG, Biberach, Germany
- 5Boehringer Ingelheim International GmbH, Ingelheim, Germany
- 6Department of Diabetes, Central Clinical School, Monash University, Melbourne, Australia
- 7Department of Medicine, Würzburg University Clinic, Würzburg, Germany
- Correspondence:
Dr. Adeera Levin, Division of Nephrology, St. Paul’s Hospital, University of British Columbia, 1081 Burrard Street Vancouver, BC V6Z 1Y6, Canada. Email: alevin{at}providencehealth.bc.ca
A.K.-W. and C.W. contributed equally to this work as senior authors.
Funding
Boehringer Ingelheim
Eli Lilly and Company